EcoDrugPlus

Protein Kinase C Alpha

Ensembl ID : ENSSMAG00000018270
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSSMAG00000021756
Gene Symbol: PRKCB
3 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSSMAG00000002587
Gene Symbol: LOC118312926
3 Cross references
223 Possible Orthologues:

Protein Kinase C Delta Type-Like

Ensembl ID : ENSSMAG00000011254
Gene Symbol: LOC118309613
2 Cross references
203 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSSMAG00000001563
Gene Symbol: PRKCDA
2 Cross references
204 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSSMAG00000001500
Gene Symbol: PRKCHA
1 Cross references
224 Possible Orthologues:

Protein Kinase C, Iota

Ensembl ID : ENSSMAG00000015695
Gene Symbol: PRKCI
3 Cross references
87 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSSMAG00000006284
Gene Symbol: PRKCQ
3 Cross references
204 Possible Orthologues:

Protein Kinase C, Zeta

Ensembl ID : ENSSMAG00000011834
Gene Symbol: PRKCZ
2 Cross references
201 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSSMAG00000007683
Gene Symbol: PRKD3
1 Cross references
201 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta, B

Ensembl ID : ENSSMAG00000011886
Gene Symbol: PTK2BB
1 Cross references
195 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11a

Ensembl ID : ENSSMAG00000010396
Gene Symbol: PTPN11A
3 Cross references
251 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).